The Division of Molecular Medicine focuses on the manipulation of genes and proteins to create novel therapies for inherited disorders and acquired and infectious diseases. Current projects include:
- Studies of the mechanism and control of processes critical to antigen-receptor diversity in Fredrick Alt's laboratory.
- Studies of the structures of viral proteins that mediate entry into cells in Stephen Harrison's laboratory.
- Investigations of the feasibility of gene transfer for treating certain inherited diseases involving hematopoietic cells and for anti-cancer therapies targeting the tumor vasculature in Richard Mulligan's laboratory.
Featured researchers in the Division of Molecular Medicine hold faculty appointments at Harvard Medical School.
